ClinicalTrials.gg
Not yet recruitingNCT06280989Updated Apr 2, 2026

Effect of Kinesio Taping Versus Myofascial Release on Menstrual Low Back Pain

An interventional study of kinesio taping and myofascial release technique in Low Back Pain, sponsored by Cairo University. Not yet recruiting at 1 site in Egypt. Open to female participants aged 18 Years to 25 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-04-02.

Sponsored by Cairo University · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
44
Allocation
Randomized
Ages
18 Years to 25 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 74 studies in Low Back Pain by Cairo University — 33 open to participants now, 33 under way, none of them phase 3. Low Back Pain · Cairo University.

Planned enrollment
49th of 65
44 · median 60
Started
2026
with 8 others
No phase
65 of 74
29 open now
Primary completion
2026-12
later than 28 of 32 live
Registered
31st of 74
by date

Among the 74 studies in Low Back Pain by Cairo University, this one is the 49th largest by planned enrollment of the 65 interventional ones that give a count, is one of 9 that started in 2026, is one of 65 with no phase, reaches primary completion later than 28 of the 32 other live ones, and was the 31st registered.

Low Back Pain

2,930 studies on the registry are indexed under Low Back Pain; 581 are open to participants now.

Browse Low Back Pain studies →

Open to participants now

33 of the 74 studies in Low Back Pain by Cairo University are open now, in 2 countries. Recruiting first, the newest first:

27 more — sign in →

By country, each count listing its studies:

All 33 open studies →

Where they have run

Who these studies take

Of the 332 Low Back Pain studies recruiting now, 93 (28%) set no upper age limit and 209 (63%) stop at 75 or younger; 8 take children under 18; 46 take healthy volunteers.

This study: 18 Years to 25 Years · female · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 74 studies in Low Back Pain by Cairo University, or all of them as a file.
02

Study summary

the aim of this study is to investigate the efficacy of kinesio taping versus myofascial release technique on menstrual low back pain in young females

Read the detailed description

: Menstrual low back pain is a prevalent condition among women. Menstrual low back pain occurrence is affected by hormonal changes. Menstrual low back pain incidence more than 40% to 50% during the menstrual phase (days 1-6) of the menstrual cycle, while the range of prevalence was 45 to 95%. It has a high prevalence among females, especially females aged 20 to 25 years old. Hormonal changes might play an important role in the formation of Menstrual low back pain and is the main cause of feeling of pain during menstrual cycle. kinesio taping and myofascial release technique play an important role in the treatment of Menstrual low back pain. this trial has two groups; one will receive kinesio taping three days and the second will receive myofascial release technique for12 sessions through 3 consecutive menstrual cycle

03

Conditions studied

  • Low Back Pain

Browse trials for

Keywords

  • kinesio taping
  • myofascial release technique
04

Who can participate

Ages eligible
18 Years to 25 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Healthy young virgin females suffering from menstrual low back pain diagnosed by the gynecologist.
  2. Their ages will be ranged from 18-25 years\' old
  3. Their will be ranged from 20-25 kg/m2.
  4. All females have regular menstruation
  5. Their pain intensity is scored as > 4 on VAS just before or during the first 3 days of the menstruation

    -

Exclusion criteria

Exclusion Criteria:

Females will be excluded from the study if they have:

  1. Any orthopedic problems such as trauma at lower spine, congenital malformation at spine and scoliosis.
  2. Any gynecological problem such as irregular menstrual cycle, secondary dysmenorrhea due to endometriosis, ovarian cyst, uterine fibroid and congenital malformation or pelvic inflammation.
  3. Athletic females
  4. Allergy to kinesio taping.

    -

Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
44 participants (estimated)

Study arms

  • Experimental
    kinesio taping

    Each female will be treated by Kinesio tape which will be applied for three days (from the first day to the end of the third day of menstrual cycle) throughout 3 consecutive cycles.

    Other: kinesio taping

  • Experimental
    myofascial release technique

    Each female will be treated by myofascial relaxation technique which will be started at the third or fourth day of menstruation and continued till the onset of the next menstruation, 40 minutes, 3 times / week for 12 sessions through 3 consecutive menstrual cycle

    Other: myofascial release technique

Interventions

  • Otherkinesio taping

    Before treatment, all female participants will undergo an allergic test on the anterior surface of the elbow. To ensure cleanliness, alcohol will be used to clean the areas to be evaluated before applying the tape. The H technique will be employed to apply KT over the lumbar region. Participants will be instructed to bend forwards from the waist, and two vertical strips will be applied. These strips will stretch the Golgi tendon organ on both sides of the spine from the top of the buttock cleft upwards to a mid-point, with less than 25% stretch . Additionally, a horizontal strip will be attached across the left and right sacroiliac joints. This strip will be stretched to 50% of its maximum capacity,.

  • Othermyofascial release technique

    myofascial release technique will be applied from prone on lumbar paravertebral muscles by using the olecranon of the physical therapist for 3 minutes, thoracolumbar fascia by using cross-handed hold, with hands placed on the T12-L1 levels and on the sacrum for 5 minutes without repetition and quadratus lumborum by using elbow with low pressure obliquely towards the center of the column for 7 min. Additionally, from supine on psoas muscle by transversal sliding of the psoas fascia. The therapist will place the hands laterally 3 cm from the umbilicus.

06

What researchers measure

Primary outcomes

  1. pain intensity

    The scale that will be used the VAS ;each subject will instructed to put point on line from no pain to tolerable pain

    Time frame: up to four weeks]

  2. pain pressure threshold

    will be measured by pressure algometer

    Time frame: up to four weeks]

Secondary outcomes

  1. severity of dysmenorrhea

    will be measured by WaLIDD scale(intensity /Wong-Baker, work ability , days of pain and location). Where (0) without dysmenorrhea, (1-4) mild dysmenorrhea, (5-7) moderate dysmenorrhea, (8-12) sever dysmenorrh

    Time frame: up to four weeks]

  2. Assess the function disability level

    will be assess by Oswestry Disability Index (ODI).

    Time frame: up to four weeks]

07

Study locations

1 site
  • Hala mohamed ahmed morsy
    Giza, Egypt 12511, Egypt
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Nov 2026; primary completion for Dec 2026, 1 month later.

Of 1,234 non-industry interventional studies with no phase under Low Back Pain, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 26. This study's planned 1 month is below that.

Counting every sponsor, half of 1,290 studies reached it within 11 months; a quarter within 5 and three quarters within 27.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 20, 2024
First posted
Feb 28, 2024
StartEst.
Nov 15, 2026
Primary completionEst.
Dec 2026
CompletionEst.
Dec 2026
Last update
Apr 2, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 2, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06280989
Lead sponsor
Cairo University
Responsible party
Hala Mohamed Ahmed Morsy (principle investigator, Cairo University) — Principal investigator
First posted
Feb 28, 2024
Start date
Nov 15, 2026 (estimated)
Primary completion
Dec 2026 (estimated)
Completion
Dec 2026 (estimated)
Last update
Apr 2, 2026

Study contacts

Hala ma Morsy, Bachelor
Contact
halamohamed8.11.2018@gmail.com
0020-01028616865
Manal El El shafei, lecture
principal investigator · Cairo University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion